Citation Tools

Download PDFPDF

Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy

Download to a citation manager

Cite this article as:
Kenna PF, Humphries MM, Kiang A, et al
Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy